{"id":"NCT03304054","sponsor":"Catalyst Pharmaceuticals, Inc.","briefTitle":"Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG","officialTitle":"A Randomized, Placebo-control, Parallel Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients With MuSK Antibody Positive Myasthenia Gravis, and a Sample of AChR Antibody Positive Myasthenia Gravis Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-04-18","primaryCompletion":"2020-01-31","completion":"2020-03-15","firstPosted":"2017-10-06","resultsPosted":"2021-08-13","lastUpdate":"2024-03-12"},"enrollment":93,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Myasthenia Gravis, Generalized"],"interventions":[{"type":"DRUG","name":"Amifampridine Phosphate","otherNames":[]},{"type":"DRUG","name":"Placebo Oral Tablet","otherNames":[]}],"arms":[{"label":"amifamapridine phosphate tablets","type":"EXPERIMENTAL"},{"label":"placebo tablets","type":"PLACEBO_COMPARATOR"}],"summary":"Efficacy and safety of amifampridine phosphate in improving the activities of daily living for patients with antibody positive MuSK myasthenia gravis.","primaryOutcome":{"measure":"Myasthenia Gravis-Activities of Daily Living (MG-ADL) Summary by Time Point and Myasthenia Gravis Type: Wilcoxon-Mann-Whitney Rank Sum Test Results","timeFrame":"Last day (Day 0) of the Run-in period and at the post-treatment visit (i.e., day 10 or the time point at which a patient discontinued treatment early).","effectByArm":[{"arm":"Amifampridine Phosphate - MuSK","deltaMin":4.96,"sd":2.915},{"arm":"Placebo - MuSK","deltaMin":3.86,"sd":2.103},{"arm":"Amifampridine Phosphate - AChR","deltaMin":6.14,"sd":3.388},{"arm":"Placebo - AChR","deltaMin":7,"sd":4.175}],"pValues":[{"comp":"OG000 vs OG001 vs OG002 vs OG003","p":"0.2196"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":86},"commonTop":["Paraesthesia oral","Paraesthesia","Nausea","Diarrhoea","Fatigue"]}}